Ethical Considerations for safeguarding human participants in pandemic research: a rapid review protocol

HRB Open Res. 2020 Jul 20:3:22. doi: 10.12688/hrbopenres.13053.2. eCollection 2020.

Abstract

COVID-19 is a respiratory disease caused by a coronavirus, designated SARS-CoV-2, which is responsible for a global pandemic in 2020. Public interest in this disease has led to the publication of thousands of articles in the medical literature in a very short timeframe. It is imperative that medical research into COVID-19 is conducted quickly and safely, and that due reference is given to the ethical considerations enshrined in the ICH GCP guidelines, according to the Declaration of Helsinki. In order to review the reporting of ethical considerations in these papers, we hereby propose a protocol for a systematic review of COVID-19 papers up to April 14 th 2020. The search criteria proposed for the review are based upon what would be a reasonable search conducted by a lay member of the public with access to PubMed.gov. Institutional Research Ethics Committees (RECs) face significant challenges in providing thorough and timely ethical review during the COVID-19 pandemic. It is proposed to publish the findings of this rapid review along with a summary of an institutional REC response to the challenges of reviewing and approving clinical research proposals in the time of a pandemic.

Keywords: COVID-19; case studies; clinical trials; pandemic; research ethics.

Associated data

  • figshare/10.6084/m9.figshare.12249224.v1

Grants and funding

This study was funded by the Health Research Board, Ireland (grant numbers HRB-TMRN-2017-1, HRB-CRCI-OR-2020-6).